EUVIMEDEUVIMED entdecken
Crossref

Lactate‐Weaponized Microspheres Amplify IL‐2–Driven Immuno‐Embolization for Hepatocellular Carcinoma

Minjiang Chen iD, Kun Zhang, Kai Li, Hui Xu, Jiayi Shi, Huilin Hu, Qianhui He, Liyun Zheng, Shiji Fang iD, Qiaoyou Weng iD, Min Xu, Zhongwei Zhao und 2 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Minjiang Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biote…. Hauptthemen laut MEDLINE: Interleukin-2, Microspheres, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, "Pioneer" and "Leading Goose" R&D Program of Zhejiang, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The acidic and immunosuppressive tumor microenvironment (TME) remarkably hampers the therapeutic efficacy of transcatheter arterial embolization (TAE) for hepatocellular carcinoma (HCC). Herein, uniform CaCO 3 nanoparticles encapsulated nickel–alginate microspheres (CaNPs/Ni‐Alg MSs) were engineered using a microfluidic device, serving as an immune‐regulated embolic agent to amplify TAE treatment of HCC. CaNPs/Ni‐Alg MSs could adsorb His‐tagged interleukin‐2 (IL‐2) and enable sustained release through coordination interactions between the His‐tag and Ni 2 + , thereby reducing systemic cytokine elevation risk from IL‐2 administration. IL‐2‐loaded microspheres (IL‐2/CaNPs/Ni‐Alg MSs) effectively neutralize intratumoral lactic acid (LA) via CaCO 3 , modulating the acidic TME. Proton neutralization restores IL‐2 activity, enhancing T lymphocyte infiltration and proliferation. Additionally, lactate made available following acid neutralization may serve as a metabolic substrate, as supported by the calcium lactate and neutralization‐mimicking experiments in vitro, contributing to CD8 + T‐cell metabolic fitness. IL‐2/CaNPs/Ni‐Alg MSs could reprogram the TME into an immune‐promoting milieu, synergizing with immune checkpoint blockade (ICB) therapy to suppress both primary and distant tumors. Not surprisingly, TAE with IL‐2/CaNPs/Ni‐Alg MSs combined with αPD‐L1 achieved superior therapeutic efficacy without side effect in a rat orthotopic HCC model. Overall, this work presents a safe metabolism‐reprogramming embolic strategy that repurposes LA to boost IL‐2–mediated embolization‐immunotherapy in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-2MicrospheresCarcinoma, HepatocellularLiver NeoplasmsEmbolization, TherapeuticLactic AcidAnimalsHumansRatsCell Line, TumorTumor MicroenvironmentMaleAlginatesMiceCalcium Carbonate

Stichwörter der Autor:innen

embolizationhepatocellular carcinomaimmunotherapyinterleukin‐2monodisperse microspheres

Substanzen

Interleukin-2Lactic AcidAlginatesCalcium Carbonate

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University,…
  • Department of Radiology, Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
  • Clinical College of the Affiliated Central Hospital, School of Medicine, Lishui University, Lishui, China.
  • Key Laboratory of Precision Medicine of Lishui, Lishui Central Hospital, Lishui, China.
  • International Clinical School, Hangzhou Medical College (Lishui Central Hospital), Lishui, China.

ORCID-Profile: Minjiang Chen, Shiji Fang, Qiaoyou Weng, Jiansong Ji

Förderung

  • National Natural Science Foundation of China
  • "Pioneer" and "Leading Goose" R&D Program of Zhejiang
  • Natural Science Foundation of Zhejiang Province
  • Zhejiang Medicine and Health Science and Technology Project
  • Lishui Innovation Consortium-Key R&D Program Projects

Zitieren

APA

Chen, M., Zhang, K., Li, K., Xu, H., Shi, J., Hu, H., He, Q., Zheng, L., Fang, S., Weng, Q., Xu, M., Zhao, Z., Shu, G., & Ji, J. (2026). Lactate‐Weaponized Microspheres Amplify IL‐2–Driven Immuno‐Embolization for Hepatocellular Carcinoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71749

Vancouver

Chen M, Zhang K, Li K, Xu H, Shi J, Hu H, et al. Lactate‐Weaponized Microspheres Amplify IL‐2–Driven Immuno‐Embolization for Hepatocellular Carcinoma. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71749

BibTeX
@article{Chen2026,
  author = {Chen, Minjiang and Zhang, Kun and Li, Kai and Xu, Hui and Shi, Jiayi and Hu, Huilin and He, Qianhui and Zheng, Liyun and Fang, Shiji and Weng, Qiaoyou and Xu, Min and Zhao, Zhongwei and Shu, Gaofeng and Ji, Jiansong},
  title = {Lactate‐Weaponized Microspheres Amplify IL‐2–Driven Immuno‐Embolization for Hepatocellular Carcinoma},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71749}
}
Kostenlos starten →